Page last updated: 2024-10-30

losartan and Kidney, Polycystic

losartan has been researched along with Kidney, Polycystic in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Awazu, M1
Yamada, M1
Asada, N1
Hashiguchi, A1
Kosaki, K1
Matsumura, K1
Keith, DS1
Torres, VE1
Johnson, CM1
Holley, KE1

Other Studies

2 other studies available for losartan and Kidney, Polycystic

ArticleYear
A girl with a mutation of the ciliary gene CC2D2A presenting with FSGS and nephronophthisis.
    CEN case reports, 2022, Volume: 11, Issue:1

    Topics: Child; Child, Preschool; Cytoskeletal Proteins; Female; Fibrosis; Glomerulosclerosis, Focal Segmenta

2022
Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1994, Volume: 24, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compoun

1994